Epigentek Home

Product Categories

EED Monoclonal Antibody [3B12]


Base Product #: A-3110              Availability: Usually Ships in 2-3 Days
Share:
Displaying 1 to 1 (of 1 products) Result Pages:  1 
 Catalog No.+   Product Name   Select Qty.   Price 
 A-3110-100  EED Monoclonal Antibody [3B12] (100 µg)   $388.00 
Product Overview

Description
Mouse monoclonal antibody raised against a partial recombinant EED, clone 3B12.

Size
100 µg

Purification
Protein A purified

Immunogen
EED (NP_003788, 342 a.a. ~ 442 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Cross Reactivity
Human

Isotype
IgG2a Kappa

Formulation
In 1x PBS, pH 7.2

Storage
Aliquot and store at -20ºC or lower. Avoid repeated freezing and thawing. Multiple freeze/thaw cycles may result in decreased performance.

Handling Recommendations
For maximum recovery of the products, centrifuge the vial prior to opening the cap.

Applications & Suggested Dilutions*
Western Blot: 0.5-1 μg/ml
ELISA: 0.25-1 μg/ml

*The end user is responsible for determining optimal working dilutions.

Quality Control

Western Blot detection against Immunogen (37.11 KDa).

 

Note: This item was formerly catalog no. ABB-3013 (ABB3013)

Product Details

Applications

Western Blot

Applicable

Immunoprecipitation Not determined

ELISA

Applicable

Immunohistochemistry (IHC)

Not determined
Immunofluorescence Not determined
User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

Feedback Form
Epigentek is an epigenetics company that specializes in epigenetic kits, antibodies, reagents, and services for epigenetic research in DNA methylation, histone modification, and chromatin studies.

Copyright © 2012 Epigentek Group Inc. All rights reserved.
Epigentek, the Epigentek logo, and the "Complete Solutions For Epigenetics" slogan are trademarks of Epigentek Group Inc.